- Report
- November 2024
- 50 Pages
Global
From €2618EUR$2,650USD£2,179GBP
- Report
- November 2024
- 50 Pages
Global
From €2618EUR$2,650USD£2,179GBP
- Report
- November 2024
- 50 Pages
Global
From €2618EUR$2,650USD£2,179GBP
- Report
- November 2024
- 50 Pages
Global
From €2618EUR$2,650USD£2,179GBP
- Report
- November 2024
- 50 Pages
Global
From €2618EUR$2,650USD£2,179GBP
- Report
- November 2024
- 50 Pages
Global
From €2618EUR$2,650USD£2,179GBP
- Report
- November 2024
- 50 Pages
Global
From €2618EUR$2,650USD£2,179GBP
- Report
- November 2024
- 50 Pages
Global
From €2618EUR$2,650USD£2,179GBP
- Report
- November 2024
- 50 Pages
Global
From €2618EUR$2,650USD£2,179GBP
- Report
- November 2024
- 50 Pages
Global
From €2618EUR$2,650USD£2,179GBP
- Report
- July 2022
- 132 Pages
Global
From €840EUR$850USD£699GBP
- Report
- June 2022
- 230 Pages
Global
From €3415EUR$3,456USD£2,842GBP
The Immunosuppressive Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs that suppress the immune system. These drugs are used to treat autoimmune diseases, organ transplant rejection, and other conditions where the immune system is overactive. Immunosuppressive drugs work by blocking the action of certain cells in the immune system, preventing them from attacking healthy tissue.
Immunosuppressive drugs are typically administered orally or intravenously, and can be used in combination with other treatments such as steroids or chemotherapy. Common side effects of immunosuppressive drugs include nausea, vomiting, diarrhea, and increased risk of infection.
Some of the major companies in the Immunosuppressive Drugs market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more